Our latest news and guidance for those working in health and social care. Subscribe for implementation advice and case studies, consultations, committee vacancies and events.
NICE newsletters and alerts
Subscribe to NICE newsletters and alerts for the latest health and care guidance, clinical updates and evidence-based resources.
Subscribe to our newsletters
Our latest news and updates for those working in the life sciences sector. Subscribe for information on our work to improve patient access to innovative new technologies, our NICE Advice support service and upcoming events.
Our latest news and guidance for GPs and other primary care colleagues. Subscribe for clinical knowledge summary updates, implementation advice and case studies, consultations, committee vacancies and events.
Our latest news and updates on our global projects and partnerships. Subscribe for information on the work of NICE International, our contribution to world-leading methods research, joint-working requests and events.
Our daily or weekly email alert service provides evidence-based information on medicines and prescribing. You can tailor the alerts you receive based on your specialities of interest.
Recent editions
NICE news for health and social care
In this edition, we look at how a more aligned pathway between NICE and the MHRA is helping bring medicines to patients and the NHS sooner, share updates to our blood transfusion guidance, dive into our latest podcast on why getting the right technology to the right patient really matters, and highlight how you can get involved in shaping the support NICE provides.
NICE expands healthtech guidance, updates diabetes treatment, boosts cancer diagnostics, supports digital mental health tools, and announces events, consultations, and resources.
January 2026
NICE approves a new at‑home prostate cancer treatment, proposes earlier spinal fracture detection, promotes digital asthma tools, and invites consultation, committee involvement, and engagement through events.
NICE news for life sciences
National Healthtech Access Programme announces first topics, changes to our cost-effectiveness thresholds.
Unlocking the potential of off-patent medicines, accelerating access to liver disease treatments.
NICE chief executive to step down at the end of 2025, innovation in action: Inside NICE's HTA Lab.
Update for primary care
In this edition, we cover a new menopause treatment now available to 500,000 people, the thousands already benefiting from innovative migraine therapies, recent reports of invasive meningococcal disease in Kent, and our latest podcast on how the right technology can transform patient lives.
In this edition, we share the first topics announced through the National Healthtech Access Programme, highlight major updates to type 2 diabetes treatment, look at how NICE guidance is helping ease pressure on the NHS, and dive into our latest podcast on two innovative migraine treatments.
January 2026
In this edition, we explore new online support for eating disorders, smarter ovarian‑cancer testing, empowering digital tools for asthma, an inspiring asthma podcast, and fresh guidance to help practices move patients toward safer, more effective alternatives to long‑term opioid use.
NICE news international
January 2026
In this edition, discover new guidance unlocking off‑patent medicines, a framework accelerating MASH treatment access, updated cost‑effectiveness thresholds, and a joint NICE–MHRA pathway speeding lifesaving medicines to patients by several months.
Innovation in action: inside NICE's HTA Lab, our role in delivering the 10 Year Health Plan for England, improve your country's health with NICE International.
Fit for the Future – 10 Year Health Plan for England, podcast: NICE's prioritisation board: 12 months on.